The EFB President, Executive Board and staff in the Barcelona Central Office wish all of our members every happiness in the festive season, and good health in 2017. We are especially grateful to our many Institutional Members for their support, which is essential for us to increase EFB activity and influence.
The Voice of Biotechnology in Europe
EFB Position Paper on Synthetic Biology
For the European Federation of Biotechnology (EFB) "Synthetic Biology" is not a new and emerging issue, rather it reflects a continuum of advances in biotechnology. The EFB strongly supports the EU aim to promote a knowledge-based bio-economy. We therefore urge European decision makers to provide a framework in which scientific developments, including applications of so-called Synthetic Biology, can flourish while addressing safety concerns for those cases where caution is justified.
EFB supports the commonly-held view that there is no need to develop a new regulatory framework for Synthetic Biology. In those cases where a product incorporating Synthetic Biology falls under the scope of the GMO legislation and/or the Cartagena Protocol on Biosafety, existing regulatory oversight is adequate for current and foreseeable Synthetic Biology applications.
Read the complete document following the link: EFB Position Paper on Synthetic Biology .